Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization

Version 1 : Received: 6 April 2024 / Approved: 8 April 2024 / Online: 8 April 2024 (14:00:27 CEST)

How to cite: Solís, K.H.; Romero-Ávila, M.T.; Rincón-Heredia, R.; García-Sáinz, J.A. LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization. Preprints 2024, 2024040541. https://doi.org/10.20944/preprints202404.0541.v1 Solís, K.H.; Romero-Ávila, M.T.; Rincón-Heredia, R.; García-Sáinz, J.A. LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization. Preprints 2024, 2024040541. https://doi.org/10.20944/preprints202404.0541.v1

Abstract

Lysophosphatidic acid (LPA) type 3 (LPA3) receptor mutants were generated in which the sites detected phosphorylated were substituted by non-phosphorylatable amino acids. Substitutions were made in the intracellular loop 3 (IL3 mutant), the carboxyl terminus (Ctail), and both domains (IL3/Ctail). The wild-type (WT) receptor and the mutants were expressed in T-REx HEK293 cells, and the consequences of the substitutions were analyzed employing different functional parameters. Agonist- and LPA-mediated receptor phosphorylation was diminished in the IL3 and Ctail mutants and essentially abolished in the IL3/Ctail mutant, indicating that the main sites were substituted and distributed in both domains. The WT and mutant receptors increased intracellular calcium and ERK 1/2 phosphorylation in response to LPA and PMA. An increase in baseline ERK phosphorylation was detected in the IL3/Ctail mutant. LPA and PMA-induced receptor interaction with β-arrestin 2 and LPA3 internalization were severely diminished in the mutants. Mutant-expressing cells also exhibit increased baseline proliferation and response to different stimuli, which were inhibited by the antagonist Ki16425, suggesting a role of LPA receptors in this process. Migration in response to different attractants was markedly increased in the Ctail mutant, which the Ki16425 antagonist also attenuated.

Keywords

Lysophosphatidic acid: LPA; Lysophosphatidic acid receptor 3; LPA3; phosphorylation sites; signaling

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.